Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00529516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1252

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluarix
BIOLOGICAL: GSK Biologicals Influenza Vaccine GSK576389A

Sponsor

GlaxoSmithKline